Literature DB >> 18370520

The role of transdermal fentanyl in palliative care: a case study series.

L O'Síoráin1.   

Abstract

Entities:  

Year:  1998        PMID： 18370520     DOI： 10.2165/00044011-199816010-00009

Source DB:  PubMed          Journal:  Clin Drug Investig        ISSN： 1173-2563            Impact factor:   2.859


× No keyword cloud information.
  4 in total

Review 1.  Transdermal fentanyl. A review of its pharmacological properties and therapeutic efficacy in pain control.

Authors:  W Jeal; P Benfield
Journal:  Drugs       Date:  1997-01       Impact factor: 9.546

2.  Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life. The TTS-Fentanyl Comparative Trial Group.

Authors:  S Ahmedzai; D Brooks
Journal:  J Pain Symptom Manage       Date:  1997-05       Impact factor: 3.612

Review 3.  Morphine in cancer pain: modes of administration. Expert Working Group of the European Association for Palliative Care.

Authors: 
Journal:  BMJ       Date:  1996-03-30

4.  Transdermal fentanyl for cancer pain. Repeated dose pharmacokinetics.

Authors:  R K Portenoy; M A Southam; S K Gupta; J Lapin; M Layman; C E Inturrisi; K M Foley
Journal:  Anesthesiology       Date:  1993-01       Impact factor: 7.892
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.